Abramson Cancer Center

Clinical Trials

Thyroid Cancer Trials

• A Phase 1 Study of the Safety, Tolerability, Pharmacokinetics and Immunoregulatory Activity of BMS-663513 (Anti-CD137) in Subjects With Advanced and/or Metastatic Solid Tumors


• A Phase II Study of Everolimus and Sorafenib in Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Sorafenib Alone


• An Open-Label, Multi-Center Phase II Study of the BRAF Inhibitor RO5185426 in Patients With Metastatic or Unresectable Papillary Thyroid Cancer (PTC) Positive for the BRAF V600 Mutation and Resistant to Radioactive Iodine


• Long-Term Chamomile Therapy for Generalized Anxiety Disorder (GAD)